Westhouse Medical Services plc
Westhouse Medical Services Plc Launches to Drive Effectiveness and Increase Quality in Primary Healthcare Provision
Westhouse Medical Services plc / Key word(s): Miscellaneous
Westhouse Medical Services Plc Launches to Drive Effectiveness and Increase Quality in Primary Healthcare Provision Lists on Open Standard Section of Frankfurt Stock Exchange LONDON, UK, 27 October 2011 – Westhouse Medical Services Plc today launches by listing in the Open Standard Section of the Frankfurt Stock Exchange (Ticker Code 5WM). Westhouse Medical is a specialist creating value for investors, providers and patients by delivering step changes in the effectiveness and quality of healthcare delivery. The newly-formed company does this through identifying and commercialising innovative medical technologies and improving the performance of patient care service businesses in high growth primary healthcare sectors that are open to competitive tender. Westhouse Medical currently consists of two wholly-owned subsidiaries: Medical Services; and Medical Devices. The company plans to grow further through the acquisition and expansion of other healthcare businesses within Europe and North America.
Patient transfer and breast screening
Experienced management team Managing director of the Medical Services subsidiary, Stewart Lawson, has been the driving force behind the market success of AST Ambulance Services, acquired by Westhouse Medical. Within six months under Lawson's management as operations director, AST experienced 36 per cent growth in turnover and quickly became profitable. AST is a market leader in the UK private ambulance services sector.
Demand for primary healthcare services will continue to rise 'In such an environment it is essential that new ways are found to simultaneously increase the efficiency and quality of primary healthcare provision both in the private and public sector. This will involve private-sector investment and expertise. That's why Westhouse Medical is building a balanced portfolio of pre-and post-revenue businesses that will both develop and deliver medical technologies and patient services.' Kaye continues: 'Westhouse Medical understands how to create value for investors, service providers and patients through delivering improved effectiveness and quality in primary healthcare. The appointment of the managing director of the Medical Devices subsidiary will be announced shortly.' ~ends~
For press information, contact:
About Westhouse Medical Listed in the Open Section of the Frankfurt Stock Exchange (Ticker code 5WM), Westhouse Medical is currently composed of two wholly-owned subsidiaries; Medical Services, providing specialist patient transfer and ambulance services; and Medical Devices, which is developing innovative new cost-effective healthcare technologies, including new breast cancer screening devices. Westhouse Medical Services PLC plans to grow through the acquisition and development of other leading medical businesses within Europe and North America, under the leadership of CEO Jack Kaye – who brings over 35 years of global technology and services business management expertise to the company. Westhouse Medical – Primary Healthcare Effectiveness Delivered. End of Corporate News 27.10.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
143647 27.10.2011 |